Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Mar. 31, 2022 $ (143,737) $ 605 $ 624,805 $ (767,724) $ (1,423)
Beginning balance (in shares) at Mar. 31, 2022   60,433,000      
Increase (Decrease) in Stockholders' Equity          
Net income (8,190)     (8,190)  
Foreign currency translation adjustments, net (1,094)       (1,094)
Shares issued under employee stock purchase plan 472 $ 3 469    
Shares issued under employee stock purchase plan (in shares)   300,000      
Shares issued under employee incentive plans, net 0 $ 20 (20)    
Shares issued under employee incentive plans, net (in shares)   2,050,000      
Shares issued in connection with business acquisition (in shares)   361,000      
Shares issued in connection with business acquisition 0 $ 4 (4)    
Shares issued in connection with rights offering, net (in shares)   30,000,000      
Shares issued in connection with rights offering, net 66,246 $ 300 65,946    
Stock-based compensation 8,340   8,340    
Ending balance at Dec. 31, 2022 $ (77,963) $ 932 699,536 (775,914) (2,517)
Ending balance (in shares) at Dec. 31, 2022 93,144,000 93,144,000      
Beginning balance at Sep. 30, 2022 $ (82,535) $ 922 696,567 (776,027) (3,997)
Beginning balance (in shares) at Sep. 30, 2022   92,158,000      
Increase (Decrease) in Stockholders' Equity          
Net income 113     113  
Foreign currency translation adjustments, net 1,480       1,480
Shares issued under employee incentive plans, net 0 $ 6 (6)    
Shares issued under employee incentive plans, net (in shares)   625,000      
Shares issued in connection with business acquisition (in shares)   361,000      
Shares issued in connection with business acquisition 0 $ 4 (4)    
Rights offering expenses (2)   (2)    
Stock-based compensation 2,981   2,981    
Ending balance at Dec. 31, 2022 $ (77,963) $ 932 699,536 (775,914) (2,517)
Ending balance (in shares) at Dec. 31, 2022 93,144,000 93,144,000      
Beginning balance at Mar. 31, 2023 $ (84,369) $ 936 702,370 (786,094) (1,581)
Beginning balance (in shares) at Mar. 31, 2023 93,574,000 93,574,000      
Increase (Decrease) in Stockholders' Equity          
Net income $ (22,342)     (22,342)  
Foreign currency translation adjustments, net 994       994
Shares issued under employee incentive plans, net 0 $ 23 (23)    
Shares issued under employee incentive plans, net (in shares)   2,276,000      
Warrants issued in connection with debt refinancing 49   49    
Stock-based compensation 3,737   3,737    
Ending balance at Dec. 31, 2023 $ (101,931) $ 959 706,133 (808,436) (587)
Ending balance (in shares) at Dec. 31, 2023 95,850,000 95,850,000      
Beginning balance at Sep. 30, 2023 $ (94,433) $ 956 705,230 (798,567) (2,052)
Beginning balance (in shares) at Sep. 30, 2023   95,519,000      
Increase (Decrease) in Stockholders' Equity          
Net income (9,869)        
Foreign currency translation adjustments, net 1,465       1,465
Shares issued under employee incentive plans, net 0 $ 3 (3)    
Shares issued under employee incentive plans, net (in shares)   331,000      
Stock-based compensation 906   906    
Ending balance at Dec. 31, 2023 $ (101,931) $ 959 $ 706,133 $ (808,436) $ (587)
Ending balance (in shares) at Dec. 31, 2023 95,850,000 95,850,000